Announce Date | 08/04/2025 |
EPS Normalized Actual | $0.17 (Miss by $-0.01) |
EPS GAAP Actual | $0.17 (Miss by $-0.01) |
Revenue Actual | $0.544833B |
Revenue Surprise | Beat by $544.833M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.10818 |
EPS GAAP Estimate | $0.10818 |
Revenue Estimate | $0.360665808B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 1.565 | 37.78 | 1.20746 | 1.73375 | 3 |
Dec 2028 | 1.11 | 53.26 | 1.06711 | 1.1537 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.19 | 0.08177 | 0.544833B | 42.07% | 189.8M |
FQ1 2025 (Mar 2025) | 0.22 | 0.22 | 0.58601B | 52.53% | 586.01M |
FQ4 2024 (Dec 2024) | 0.12 | 0.12 | 0.481139B | 48.74% | 481.14M |
FQ3 2024 (Sep 2024) | 0.35 | 0.35 | 0.401556B | 43.54% | 401.56M |
FQ1 2019 (Mar 2019) | -0.27 | -0.27 | 0.0180525B | 100% | 18.05M |
FQ2 2019 (Jun 2019) | -0.27 | -0.27 | 0.0180525B | 100% | 18.05M |
FQ2 2024 (Jun 2024) | 0.062 | 0.062 | 0.315648B | 34.13% | 315.65M |
FQ1 2024 (Mar 2024) | 0.0521 | 0.0521 | 0.278171B | 100% | 278.17M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.10818
Consensus Revenue Estimates
0.360665808B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.24984 | -- | 0.24132 | 0.26537 | 1 |
FQ3 2027 (Sep 2027) | 0.38928 | -- | 0.36524 | 0.40435 | 1 |
FQ2 2027 (Jun 2027) | 0.42203 | -- | 0.39597 | 0.43837 | 1 |
FQ1 2027 (Mar 2027) | 0.39257 | -- | 0.36833 | 0.40777 | 1 |
FQ4 2026 (Oct 2026) | 0.2411 | -- | 0.23796 | 0.24555 | 3 |
FQ3 2026 (Jul 2026) | 0.2264 | -- | 0.22345 | 0.23058 | 5 |
FQ2 2026 (Jun 2026) | 0.2264 | 16.08 | 0.22474 | 0.2291 | 3 |
FQ1 2026 (Mar 2026) | 0.2154 | -2.14 | 0.21382 | 0.21797 | 3 |
FQ4 2025 (Oct 2025) | 0.11445 | -4.85 | 0.11296 | 0.11656 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.92B | -- | 0.89B | 0.96B | 3 |
FQ3 2027 (Sep 2027) | 0.81B | -- | 0.77B | 0.83B | 4 |
FQ2 2027 (Jun 2027) | 0.77B | -- | 0.73B | 0.79B | 6 |
FQ1 2027 (Mar 2027) | 0.74B | -- | 0.7B | 0.76B | 4 |
FQ4 2026 (Oct 2026) | 0.48B | -- | 0.48B | 0.49B | 4 |
FQ3 2026 (Jul 2026) | 0.46B | -- | 0.45B | 0.47B | 6 |
FQ2 2026 (Jun 2026) | 0.46B | -18.81 | 0.46B | 0.46B | 5 |
FQ1 2026 (Mar 2026) | 0.44B | -32.33 | 0.44B | 0.45B | 6 |
FQ4 2025 (Oct 2025) | 0.38B | -27.04 | 0.37B | 0.38B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.10823 | 0.19 | 0.08177 | 43.04% |
FQ1 2025 (Mar 2025) | 0.22 | 0.22 | 100% | |
FQ4 2024 (Dec 2024) | 0.12 | 0.12 | 100% | |
FQ3 2024 (Sep 2024) | 0.35 | 0.35 | 100% | |
FQ1 2019 (Mar 2019) | -0.27 | -0.27 | 100% | |
FQ2 2019 (Jun 2019) | -0.27 | -0.27 | 100% | |
FQ2 2024 (Jun 2024) | 0.062 | 0.062 | 100% | |
FQ1 2024 (Mar 2024) | 0.0521 | 0.0521 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0.36B | $0.54B | $189.8M | 34.84% |
FQ1 2025 (Mar 2025) | $0B | $0.59B | $586.01M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.48B | $481.14M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.4B | $401.56M | 100% |
FQ1 2019 (Mar 2019) | $0B | $0.02B | $18.05M | 100% |
FQ2 2019 (Jun 2019) | $0B | $0.02B | $18.05M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.32B | $315.65M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.28B | $278.17M | 100% |